JAS reports zero serious injuries in ten-year analysis
Over 167,000 patients treated with Joint Active Systems SPS devices showed no serious injuries and achieved excellent clinical outcomes.
See the latest news and media coverage for JAS. We track all announcements, press releases, and industry mentions in real time, all in one place.
Manufacturer of orthopedic rehabilitation devices
jointactivesystems.comLast updated
In short: JAS reported its elbow device helped 90% of patients avoid surgery, with average flexion improving 41 degrees.
Over 167,000 patients treated with Joint Active Systems SPS devices showed no serious injuries and achieved excellent clinical outcomes.
The dynamic range features a single solution to help users regain both movement capabilities simultaneously.
90% of patients avoided operative treatment with the JAS elbow device, achieving an average 41-degree improvement in flexion. This outcome addresses common complications like stiffness following FOOSH injuries.
Services may be unavailable while the team works to fix the situation.
On February 1, North Carolina Attorney General Josh Stein announced that his Medicaid Investigations Division reached a $500,000 settlement with Joint Active Systems, Inc. (JAS...
Track JAS and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to JAS and other trending companies.